FDA Approves New Device for Enlarged Prostate Treatment

Indonesia Berita Berita

FDA Approves New Device for Enlarged Prostate Treatment
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Medscape
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 55%

The FDA has approved a new catheter designed to treat urinary tract symptoms of an enlarged prostate, also known as benign prostate hyperplasia.

, both showed that the Optilume BPH system improved urinary flow rate and decreased the amount of urine stored in the bladder following urination. Men who used the OPTILUME device were able to ejaculate normally and reported no sexual difficulties.

"Optilume BPH is the next generation of minimally invasive technology, creating a new drug device space among BPH therapies," said Steven A. Kaplan, MD, professor of urology at the Icahn School of Medicine at Mount Sinai in New York City, in the press release. Kaplan led the EVEREST-1 and PINNACLE studies, which Urotronic funded.Marcus A. Banks, MA, is a journalist based in New York City who covers health news with a focus on new cancer research.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Medscape /  🏆 386. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Better Therapeutics stock surges on 'big milestone' after FDA approves smartphone-based diabetes treatmentBetter Therapeutics stock surges on 'big milestone' after FDA approves smartphone-based diabetes treatmentBetter Therapeutics shares surged in the extended session Monday after the company got FDA approval for its smartphone-based behavioral diabetes therapy.
Baca lebih lajut »

FDA Approves Cognitive Behavioral App for Adults With T2DFDA Approves Cognitive Behavioral App for Adults With T2DA smartphone app that delivers cognitive behavioral therapy to adults with type 2 diabetes received US FDA marketing approval on July 10, with prescribing and sales slated to start later in 2023.
Baca lebih lajut »

Autauga County school board approves contract for new superintendentAutauga County school board approves contract for new superintendentStarting July 12, Lyman Woodfin will be the superintendent for Autauga County Schools.
Baca lebih lajut »

Extreme flooding overwhelms New York roadways and kills 1 person - New York Amsterdam NewsExtreme flooding overwhelms New York roadways and kills 1 person - New York Amsterdam NewsHeavy rain spawned extreme flooding in New York’s Hudson Valley that killed at least one person, swamped roadways and forced road closures on Sunday night, as much of the rest of the Northeast U.S. braced Monday for potentially punishing rains.
Baca lebih lajut »

2023 Mitsubishi Triton detailed with new frame, new diesel engine - Autoblog2023 Mitsubishi Triton detailed with new frame, new diesel engine - AutoblogThe next-generation Mitsubishi Triton (known as the L200 in some markets) due out in July 2023 will receive a new frame and a new turbodiesel engine.
Baca lebih lajut »

Air Force delays bonuses and new assignments amid political feud over Space Command’s new headquartersAir Force delays bonuses and new assignments amid political feud over Space Command’s new headquartersThe U.S. Air Force says it has delayed planned moves for its personnel and re-enlistment bonuses after Alabama lawmakers blocked funding for the service amid a political quarrel over the location of Space Command’s new headquarters.
Baca lebih lajut »



Render Time: 2025-02-28 12:13:37